SCHEMBL2581339

SCHEMBL2581339

O=C(NC1CCCC1)C1=NOC2(CCN(C(=O)c3ccc([N+](=O)[O-])cc3Cl)CC2)C1

nearest known ligand 0.49

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.44
EPHX2 P34913 2/20 0.40
MAPT P10636 3/20 0.40
TP53 P04637 1/20 0.40
NPC1 O15118 1/20 0.40
POLB P06746 2/20 0.39
CTDSP1 Q9GZU7 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
LMNA P02545 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6410889 0.86 MAPT (0.39) ALDH1A1EPHX2MAPTTP53NPC1
SCHEMBL15309174 0.85 ALDH1A1 (0.44) ALDH1A1MAPTTP53NPC1POLB
SCHEMBL2583086 0.78 CYP2C19 (0.44) ALDH1A1EPHX2MAPTPOLBLMNA
SCHEMBL6848466 0.77 KDM4E (0.41) ALDH1A1EPHX2MAPTNPC1POLB
SCHEMBL2401204 0.74 LMNA (0.46) ALDH1A1MAPTTP53NPC1POLB
SCHEMBL3510744 0.73 ALDH1A1 (0.50) ALDH1A1EPHX2MAPTTP53NPC1
SCHEMBL2399960 0.73 ALDH1A1 (0.41) ALDH1A1MAPTPOLBL3MBTL1LMNA
SCHEMBL2400381 0.73 EPHX2 (0.51) EPHX2MAPTNPC1CTDSP1TDP1
SCHEMBL3427781 0.71 MAPT (0.72) ALDH1A1MAPTTP53NPC1POLB
SCHEMBL2402512 0.71 EPHX2 (0.49) ALDH1A1EPHX2MAPTCTDSP1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8048890-B2 Analgesics; neuropathic pain; headaches; muscle relaxants; incontence; tinnitus; diarrhea; antiarrhythmia agents; antiischemic agents; antiinflammatory agents; antiulcer agents; antidepressants; antiepileptic agents GRUENENTHAL GMBH (DE) 2011-11-01 US claimed
EP-1401841-B1 SUBSTITUTED 1-OXA-2,8-DIAZA-SPIRO 4,5]DEC-2-ENE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF PAIN GRUENENTHAL GMBH (DE) 2005-08-24 EP claimed